The case of beta-blockers after myocardial infarction
Dan Atar, MD

ACEi or ARBs? The eternal question
Antonio Coca, MD, FRCP, EFESC

Novas descobertas, dogmas e mitos na PP
Fernando Araújo, MD

New developments in echocardiography
Anthony DeMaria, MD

The zero LDL cholesterol hypothesis
Luís Masana, PhD

Heart Team para os doentes com embolia pulmonar de risco alto ou intermédio-alto
Hélder Pereira, MD

Advancing into the future of advanced heart failure
José González Costello, MD

Exercise and sport participation in patients with HCM
Antonio Pelliccia, MD, FESC

Anticoagulação: segurança em doentes desafiantes
Francisco Moscoso Costa, MD

Rethink treatment decisions to management of T2D
Robert J Chilton, PhD

Chegou ao CPC 2019? Mind the app!